LeMaitre Vascular (LeMaitre Vascular) Net Change in Cash

: $5.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

LeMaitre Vascular's Net Change in Cash for the three months ended in Dec. 2023 was $6.2 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $5.1 Mil.

LeMaitre Vascular Net Change in Cash Historical Data

The historical data trend for LeMaitre Vascular's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

-14.53

14.98

-12.91

5.28

5.14

LeMaitre Vascular Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash																2.22	-2.46	2.81	-1.44	6.22

LeMaitre Vascular Net Change in Cash Calculation

LeMaitre Vascular's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	36.751	+	-24.715	+	-7.131	+	0.23
	=	5.1

LeMaitre Vascular's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 10.746 + -2.261 + -2.686 + 0.419

= 6.2

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular Net Change in Cash Related Terms
Thank you for viewing the detailed overview of LeMaitre Vascular's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

LeMaitre Vascular (LeMaitre Vascular) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » Net Change in Cash

Comparable Companies

ATRC WRBY STAA BLFS ATRI EMBC ZJYL PLSE OSUR ANIK ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543

Traded in Other Exchanges

LHU:Germany

Address

63 Second Avenue, Burlington, MA, USA, 01803

Website

https://www.lemaitre.com

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Executives

George W Lemaitre director, 10 percent owner, officer: Chairman, President and CEO 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129

Bridget A Ross director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747

John A Roush director C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409

Lawrence J Jasinski director SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760

David B Roberts director, officer: CFO and Director 55 BRADFORD STREET, NEEDHAM MA 02492

Trent G Kamke officer: Senior V. P., Operations 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132

Martha Shadan director 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445

Pellegrino Joseph P Jr officer: Executive V.P. Finance 68 BEACON STREET, BOSTON MA 02108

Michael H Thomas director P.O. BOX 2207, NOKOMIS FL 34274-2207

Peter R Gebauer officer: President, International OP AM WALDFELD 17, BAD SODEN 2M 65812

Michael T Wijas officer: VP of Sales, The Americas C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803

Lemaitre Cornelia W director, officer: V.P., Human Resources,Director 8 SUNSET ROCK ROAD, ANDOVER MA 01810

Russell D Hays director C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012

Robert V Linden officer: VP, North American Sales 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966

Thorndike William N Jr director HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199

LeMaitre Vascular (LeMaitre Vascular) Headlines

From GuruFocus

LeMaitre to Present at the Canaccord Genuity 42nd Annual Growth Conference
By PurpleRose PurpleRose • 08-01-2022

LeMaitre Vascular Inc (LMAT) Reports 21% Sales Growth in Q3 2023
By GuruFocus Research • 11-01-2023

LeMaitre Will Announce First Quarter 2023 Earnings Results May 2, 2023
By sperokesalga sperokesalga • 04-17-2023

LeMaitre to Present at Upcoming Investor Conferences in August
By GlobeNewswire • 07-31-2023

LeMaitre Q2 2023 Financial Results
By Marketwired • 08-01-2023

LeMaitre Will Announce Fourth Quarter 2022 Earnings Results February 23, 2023
By Stock market mentor Stock market mentor • 02-08-2023

LeMaitre to Participate at Upcoming Investor Conferences in November
By Marketwired • 11-03-2023

LeMaitre to Present at Upcoming Investor Conferences in August
By Marketwired • 07-31-2023

LeMaitre Will Announce Third Quarter 2023 Earnings Results November 1, 2023
By GlobeNewswire • 10-17-2023

LeMaitre to Present at Upcoming Investor Conferences
By PurpleRose PurpleRose • 07-15-2022

George W Lemaitre	director, 10 percent owner, officer: Chairman, President and CEO	342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush	director	C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski	director	SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts	director, officer: CFO and Director	55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke	officer: Senior V. P., Operations	61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan	director	9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr	officer: Executive V.P. Finance	68 BEACON STREET, BOSTON MA 02108
Michael H Thomas	director	P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer	officer: President, International OP	AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas	officer: VP of Sales, The Americas	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W	director, officer: V.P., Human Resources,Director	8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays	director	C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden	officer: VP, North American Sales	236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr	director	HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199